Update 2010 – Literaturverzeichnisse - Chemotherapie Journal

*6
Empfehlungen
16. Eick S, Pfister W, Straube E. Antimicrobial susceptibility of anaerobic
and capnophilic bacteria isolated from odontogenic abscesses and rapidly
progressive periodontitis. Int J Antimicrob Agents 1999;12:41-6.
17. Falkler WA Jr, Enwonwu CO, Idigbe EO. Microbiological understandings
and mysteries of noma (cancrum oris). Oral Dis 1999;5:150-5.
18. Federspil P. Antibiotika-Therapie der Infektionen an Kopf und Hals –
Leitlinien, im Auftrag des Präsidiums der Deutschen Gesellschaft für
Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Arzneimitteltherapie
2009;27:125–42.
19. Feifel H, Friebel S, Riediger D. Verlauf und Therapie der Osteomyelitis
des Gesichtsschädels. Dtsch Zahnarztl Z 1997:691-4.
20. Franzese CB, Isaacson JE. Peritonsillar and parapharyngeal space abscess
in the older adult. Am J Otolaryngol 2003;24:169-73.
21. Gavriel H, Lazarovitch T, Pomortsev A, Eviatar E. Variations in the
microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis
2009;28:27-31.
22. Gmur R, Wyss C, Xue Y, Thurnheer T, et al. Gingival crevice microbiota
from Chinese patients with gingivitis or necrotizing ulcerative gingivitis.
Eur J Oral Sci 2004;112:33-41.
23. Grime PD, Bowerman JE, Weller PJ. Gentamicin impregnated polymethylmethacrylate
(PMMA) beads in the treatment of primary chronic
osteomyelitis of the mandible. Br J Oral Maxillofac Surg 1990;28:367-74.
24. Guldfred LA, Lyhne D, Becker BC. Acute epiglottitis: Epidemiology,
clinical presentation, management and outcome. J Laryngol Otol
2008;122:818-23.
25. Hagelskjaer Kristensen L, Prag J. Localised Fusobacterium necrophorum
infections: a prospective laboratory-based Danish study. Eur J Clin Microbiol
Infect Dis 2008;27:733-9.
26. Handzel O, Halperin D. Necrotizing (malignant) otitis. Am Fam Physician
2003;68:309-12.
27. Hanna BC, McMullan R, Gallagher G, Hedderwick S. The epidemiology
of peritonsillar abscess disease in Northern Ireland. J Infect 2006;52:247-
53.
28. Kanebayashi H, Ogawa Y, Yamanishi T, Fujita H, et al. Clinical investigation
of the peritonsillar abscess. Oto-Rhino-Laryngology Tokyo
2003;46:24-8.
29. Kinane DF, Marshall GJ. Periodontal manifestations of systemic disease.
Aust Dent J 2001;46:2-12.
30. Koorbusch GF, Fotos P, Goll KT. Retrospective assessment of osteomyelitis.
Etiology, demographics, risk factors, and management in 35 cases.
Oral Surg Oral Med Oral Pathol 1992;74:149-54.
31. Kuriyama T, Karasawa T, Nakagawa K, Nakamura S, et al. Antimicrobial
susceptibility of major pathogens of orofacial odontogenic infections to
11 beta-lactam antibiotics. Oral Microbiol Immunol 2002;17:285-9.
32. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, et al. Incidence of
beta-lactamase production and antimicrobial susceptibility of anaerobic
gram-negative rods isolated from pus specimens of orofacial odontogenic
infections. Oral Microbiol Immunol 2001;16:10-5.
33. Kuriyama T, Nakagawa K, Karasawa T, Saiki Y, et al. Past administra tion
of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing
bacteria in patients with orofacial odontogenic infections.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:186-92.
34. Ladhani S, Neely F, Heath PT, Nazareth B, et al. Recommendations for
the prevention of secondary Haemophilus influenzae type b (Hib) disease.
J Infect 2009;58:3-14.
35. Lamey PJ, Boyle MA, MacFarlane TW, Samaranayake LP. Acute suppurative
parotitis in outpatients: microbiologic and posttreatment sialographic
findings. Oral Surg Oral Med Oral Pathol 1987;63:37-41.
36. Lancaster J, Alderson DJ, McCormick M. Non-pseudomonal malignant
otitis externa and jugular foramen syndrome secondary to cyclosporininduced
hypertrichosis in a diabetic renal transplant patient. J Laryngol
Otol 2000;114:366-9.
37. Lewis MA, Lamey PJ, Gibson J. Quantitative bacteriology of a case of
acute parotitis. Oral Surg Oral Med Oral Pathol 1989;68:571-5.
38. Martin MV. The use of oral amoxycillin for the treatment of actinomycosis.
A clinical and in vitro study. Br Dent J 1984;156:252-4.
39. Marx RE. Chronic Osteomyelitis of the jaws. Oral Maxillofac Surg Clin
North Am 1991;3:367-81.
40. Megalamani SB, Suria G, Manickam U, Balasubramanian D, et al. Changing
trends in bacteriology of peritonsillar abscess. J Laryngol Otol
2008;122:928-30.
41. Michalski G, Hocke T, Hoffmann K, Esser D. Die Mastoiditis als Folge
einer akuten Otitis media – Eine retrospektive Studie Laryngo-Rhino-
Otol 2002;81:857-60.
42. Mischkowski RA, Hidding J, Gruber G, Klesper B, et al. Risikofaktoren
und Management von Abszessen im MKG-Bereich – Eine retrospektive
Studie von über 1 000 Fällen. Dtsch Zahnarztl Z 1997;52:697-700.
43. Otten JE, Weingart D, Pelz K, Poukens J. Bakterien in Sekreten extra-
und intraoraler Operationswunden Kontamination oder Infektion?
Dtsch Zahnarztl Z 1994;49:1031-3.
Chemotherapie Journal 19. Jahrgang · Heft 6 · 2010
44. Piesold J, Al-Nawas B, Otten JE, Grötz KA. Leitlinien der Deutschen Gesellschaft
für Mund-Kiefer-Gesichtschirurgie - Odontogene Infektionen
und Abszesse S2. AWMF Online; 2008; Available from: http://leitlinien.
net/.
45. Piesold J, Vent S, Schönfeldt S. Odontogene pyogene Infektionen. Mund
Kiefer Gesichtschir 1999;3:82-91.
46. Pigrau C, Almirante B, Rodriguez D, Larrosa N, et al. Osteomyelitis of the
jaw: resistance to clindamycin in patients with prior antibiotics exposure.
Eur J Clin Microbiol Infect Dis 2008; 28:317-23.
47. Pino Rivero V, Gonzalez Palomino A, Pantoja Hernandez CG, Trinidad
Ramos G, et al. Plaut-Vincent‘s acute necrotizing ulcerative fusospirillum
tonsillitis associated to infectious mononucleosis. An Otorrinolaringol
Ibero Am 2006;33:219-24.
48. Rams TE, Andriolo M Jr, Feik D, Abel SN, et al. Microbiological study of
HIV-related periodontitis. J Periodontol 1991;62:74-81.
49. Rusan M, Klug TE, Ovesen T. An overview of the microbiology of acute
ear, nose and throat infections requiring hospitalisation. Eur J Clin Microbiol
Infect Dis 2009;28:243-51.
50. Sakamoto H, Aoki T, Kise Y, Watanabe D, et al. Descending necrotizing
mediastinitis due to odontogenic infections. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod 2000;89:412-9.
51. Salama C, Finch D, Bottone EJ. Fusospirochetosis causing necrotic oral
ulcers in patients with HIV infection. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 2004;98:321-3.
52. Schaal KP, Herzog M, Pape HD, Pulverer G, et al. Kölner Therapiekonzept
zur Behandlung der menschlichen Aktinomykose von 1952–1982.
In: Schuchard K, Pfeifer G, Schwenzer N (eds.). Fortschritte der Kiefer-
und Gesichtschirurgie, 1984:151-6.
53. Shpitzer T, Stern Y, Cohen O, Levy R, et al. Malignant external otitis in
nondiabetic patients. Ann Otol Rhinol Laryngol 1993;102:870-2.
54. Simon C, Stille W. Antibiotika Therapie in Klinik und Praxis. 10th edition.
Stuttgart, New York: Schattauer Verlag; 2000.
55. Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis 1998;26:1255-61.
56. Sobottka I, Cachovan G, Sturenburg E, Ahlers MO, et al. In vitro activity
of moxifloxacin against bacteria isolated from odontogenic abscesses.
Antimicrob Agents Chemother 2002;46:4019-21.
57. Soldati D, Mudry A, Monnier P. Necrotizing otitis externa caused by Staphylococcus
epidermidis. Eur Arch Oto-Rhino-Laryngo 1999;256:439-41.
58. Tuzuner-Oncul AM, Ungor C, Dede U, Kisnisci RS. Methicillin-resistant
Staphylococcus aureus (MRSA) osteomyelitis of the mandible. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod 2009;107:e1-4.
59. Vogel F, Scholz H, et al. Rationaler Einsatz oraler Antibiotika bei Erwachsenen
und Schulkindern. Chemother J 2002;2:47-58.
60. Walter C, Grotz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate
associated osteonecrosis of the jaw within the field of osteonecrosis.
Support Care Cancer 2007;15:197-202.
61. Warnke PH, Becker ST, Springer IN, Haerle F, et al. Penicillin compared
with other advanced broad spectrum antibiotics regarding antibacterial
activity against oral pathogens isolated from odontogenic abscesses. J
Craniomaxillofac Surg 2008;36:462-7.
7. Intraabdominelle Infektionen
Christian Eckmann, Rainer Isenmann, Peter Kujath, Annette Pross, Arne C. Rodloff,
Franz-Josef Schmitz, Matthias Trautmann, Hannes Wacha
Literatur
1. Arbeit RD, Maki D, Tally FP, Campanaro E, et al. The safety and efficacy
of daptomycin for the treatment of complicated skin and skin-structure
infections. Clin Infect Dis 2004;38:1673-81.
2. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, et al. The efficacy and
safety of tigecycline for the treatment of complicated intra-abdominal
infections: analysis of pooled clinical data. Clin Infect Dis 2005;41:354-
67.
3. Bader F, Schroeder M, Kujath P, Muhl E, et al. Diffuse postoperative peritonitis
– value of diagnostic parameters and impact of early indication
for relaparotomy. Eur J Med Res 2009;14:1-6.
4. Banks PA, Gerzov SG, Langevin RE, Silverman SG, et al. CT-guided aspiration
of suspected pancreatic infection: bacteriology and clinical outcome.
Int J Pancreatol 1995;18:265-70.
5. Barie P. The cost of failure. Surg Infect 2008;9:313-5.
6. Besselink MG, Verwer TJ, Schoenmakers EJ, Buskens E, et al. Timing
of surgical intervention in necrotizing pancreatitis. Arch Surg
2007;142:1194-201.
7. Birmingham MC, Rayner CR, Meagher AM, Flavin SM, et al. Linezolid
for the treatment of multidrug-resistant, gram-positive infections: expe-